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Abstract

Résumé

Objective: An association between endometriosis and psychiatric
disturbances has been identified by some researchers. The
purpose of this systematic review was to consolidate existing
empirical findings to clarify the association between endometriosis
and psychiatric conditions.

Objectif : Une association entre l’endométriose et des perturbations
psychiatriques a été identifiée par certains chercheurs. Cette
analyse systématique avait pour but de consolider les constatations
empiriques existantes en vue de clarifier l’association entre
l’endométriose et des troubles psychiatriques.

Data Sources: We searched three electronic databases (Medline/
PubMed, PsychInfo, and ClinicalTrials.gov) using the following
search items: “endometriosis” combined with “mood,”
“bipolar disorder,” “major depressive disorder,” “anxiety,”
“psychiatric,” “psychosocial,” “antidepressants,” “antianxiety,”
“pharmacotherapy,” or “psychotherapy.”

Sources de données : Nous avons mené des recherches dans
trois bases de données électroniques (Medline/PubMed,
PsychInfo et ClinicalTrials.gov) au moyen des termes suivants :
« endometriosis » en combinaison avec « mood », « bipolar
disorder », « major depressive disorder », « anxiety »,
« psychiatric », « psychosocial », « antidepressants »,
« antianxiety », « pharmacotherapy » ou « psychotherapy ».

Study Selection: We included all relevant articles published in
English. We identified 18 original research studies examining the
association between endometriosis and psychiatric symptoms,
with a combined total of 999 endometriosis patients being
examined.
Data Extraction and Synthesis: Of the 18 studies examined, 14
reported that endometriosis was associated with at least some
aspect of reduced psychological functioning or mental health
quality of life. Tabulation of raw frequencies of the studies using
clinical diagnostic criteria and a comparison group revealed that at
least 56.4% of women (44/78) with a diagnosis of endometriosis
and 43.6% of women (48/110) without such a diagnosis met the
criteria for a psychiatric disorder.
Conclusion: The limited research suggests that women presenting
with endometriosis are at risk for psychosocial disturbances or
psychiatric distress. Whether such disruptions are a consequence
of endometriosis, the associated chronic gynaecological pain, or
another factor such as inflammation remains to be delineated. In the
interim, women presenting with symptoms of endometriosis should
also be screened for psychosocial and psychiatric disturbances.
Key Words: Anxiety, depression, endometriosis, mood disorders,
pain, therapeutics
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Sélection des études : Nous avons inclus tous les articles pertinents
publiés en anglais. Nous avons identifié 18 études originales s’étant
penchées sur l’association entre l’endométriose et des symptômes
psychiatriques (pour un total combiné de 999 cas d’endométriose
soumis à une analyse).
Extraction et synthèse des données : Parmi les 18 études
examinées, 14 ont signalé que l’endométriose était au moins d’une
certaine façon associée à une atténuation du fonctionnement
psychologique ou de la qualité de vie liée à la santé mentale. La
tabulation des fréquences brutes de ces études au moyen de critères
diagnostiques cliniques et d’un groupe de comparaison a révélé
qu’au moins 56,4 % des femmes (44/78) ayant obtenu un diagnostic
d’endométriose et 43,6 % des femmes (48/110) n’ayant pas obtenu
un tel diagnostic satisfaisaient aux critères permettant d’établir la
présence d’un trouble psychiatrique.
Conclusion : Les recherches limitées semblent indiquer que les
femmes qui présentent une endométriose sont exposées à
des risques de perturbations psychosociales ou de détresse
psychiatrique. La question de savoir si de telles perturbations sont
une conséquence de l’endométriose, de la douleur gynécologique
chronique connexe ou d’autres facteurs tels que l’inflammation
demeure à élucider. Entre-temps, les femmes qui présentent
des symptômes d’endométriose devraient également faire
l’objet d’un dépistage visant des perturbations psychosociales et
psychiatriques.
J Obstet Gynaecol Can 2015;37(11):1006–1015
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INTRODUCTION

E

ndometriosis is a benign chronic and often progressive
gynaecological condition that affects 10% to 15% of
women who are of reproductive age and is one of the main
causes of female infertility.1–3 The disorder is defined by the
presence of endometrial glands and stroma outside the uterus,
resulting in an estrogen-dependent chronic inflammatory
response.4 The American Society for Reproductive Medicine
classifies endometriosis into four stages, with stage I and
II representing initial stages and III and IV representing
advanced stages.5 A definitive cause for endometriosis
has yet to be established. However, some theories have
been proposed: the most widely accepted theory asserts
that immune dysfunction and abnormal differentiation of
endometriotic tissue are implicated in the development of the
disorder.4 Other possibilities include genetic or environmental
factors, in association with either normal or greater than
normal retrograde menstruation. Risk factors such as alcohol
and caffeine use have also been identified.6–9
Endometriosis is a major cause of disability and impaired
quality of life for women of reproductive age, because
the disorder can result in chronic and severe pelvic
pain. It is associated with dysmenorrhea, dyspareunia,
gastrointestinal problems, fatigue, headaches, deep pelvic
pain, and lower abdominal pain both with and without back
pain.7,10–12 Women with endometriosis may also experience
disturbances in work, family relationships, social life, selfesteem, and mood symptoms.13,14 In spite of the significant
potential psychosocial implications of endometriosis,
there is a paucity of research regarding the link between
endometriosis and psychiatric symptoms. Thus, we wished
to add to the existing literature by providing an overview of
what is known about the associations between psychiatric
symptoms and endometriosis. Such information is important
for treating clinicians, such as gynaecologists, because
psychiatric disorders may influence gynaecological patients’
perception and reporting of symptoms, their prognosis and
compliance with treatment, and their overall well-being.
METHODS
Sources

A literature search for this systematic review was conducted
for studies published in English prior to December 2014.
Three electronic databases (Medline/PubMed, PsychInfo,
and ClinicalTrials.gov) were searched. The following title
or abstract search items were used: “endometriosis” with
“mood,” “bipolar disorder,” “major depressive disorder,”
“anxiety,” “psychiatric,” “psychosocial,” “antidepressants,”
“antianxiety,” “pharmacotherapy,” and “psychotherapy.”

The search identified 119 articles. The reference lists of
articles identified were also searched to identify other
relevant publications.
Study Selection

All relevant articles published in English were considered
in this review; we identified 18 original quantitative
research studies examining the association between
endometriosis and psychiatric symptoms or quality of life.
Fourteen of the 18 studies used at least one comparison
group. Taken together, these studies assessed 999 women
with endometriosis and 857 women acting as controls
(397 women with chronic pelvic pain due to another
medical condition, 32 women with migraine headaches,
78 infertile women, and 350 healthy controls).
RESULTS

Details related to each of the identified 18 quantitative
studies and relevant statistics (where available) are
presented in Table 1. Fourteen of the 18 studies reported
that endometriosis or chronic pelvic pain significantly
reduced at least some aspect of psychological functioning,
mental health, or quality of life, many reporting elevated
risk for depressive, hypomanic, or anxiety symptoms. All
samples were derived from a clinical patient population,
with the exception of the study by Barnack and Chrisler,
who recruited from the community.15 Pharmacological
intervention characteristics of the sample, where available,
are also detailed in Table 1.
Only four of the identified studies16,18,29,30 used clinical
diagnostic criteria to assess for psychiatric diagnosis, and
three of these16,18,29 used a comparator group. Each of
these three studies used clinical samples of women who
ranged in age from late teens to mid-40s. Unfortunately,
only the study by Kumar and colleagues provided further
demographic patient characteristics.18 Notably, in their
study 37% of participants in the endometriosis group and
50% in the pelvic pain group reported a family history
of mood disorders; they also clarified that none of the
patients in their study were undergoing treatment with a
GnRH agonist.18 None of the studies reported on other
pharmacological, surgical, or psychosocial interventions.
Of the three studies using a comparator group, two found
women with endometriosis to be at an increased risk for a
psychiatric disorder.16,18 One of the studies used a healthy
control group16 and the other consisted of women with
chronic pelvic pain due to another medical condition.18
Combined, 44 of the 79 women with endometriosis in
these three studies (56%) met the criteria for at least one
psychiatric disorder. Not all studies assessed participants
NOVEMBER JOGC NOVEMBRE 2015 l 1007
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19

Siedentopf et al.25

Petrelluzzi et al.24

Eriksen et al.23

Sepulcri &
do Amaral22*

Roth et al.21

Kumar et al. 20

Garalejić et al.

Tripoli et al.

12

Kumar et al.18

Smorgick et al.17*

Cavaggioni et al.16

(excluded women on immunosuppressive,
hormonal, or IVF treatment)

31 (infertile women)

38 (endometriosis)

(controls not taking hormonal anti-inflammatories;
53% of the endometriosis group and 32% of controls
using OC; 7% of endometriosis group on ANT)

82 (health women)

93 (endometriosis)

20 (health women)

63 (endometriosis)

(none used NSAIDs, anxiolytics, or ANT in the
3 months preceding assessment)

104 (endometriosis)

108 (chronic pelvic pain)

30 (endometriosis with chronic pelvic pain)

100 (healthy women)

100 (chronic pelvic pain)

100 (endometriosis)

47 (infertile women)

40 (endometriosis)

50 (health women)

35 (chronic pelvic pain)

49 (endometriosis)

(none undergoing treatment with a GnRH agonist)

12 (chronic pelvic pain)

27 (endometriosis)

(136 used HT)

138 (endometriosis)

43 (control)

37 (endometriosis)

(during study 19 using ANT and 23 using HT;
45 ever used HT)

79 (endometriosis)

Carey et al. *

1

Number of sample
(pharmacological characteristics)

Source

Stress and depression

Stress and mental health
quality of life

Depression and anxiety

Depression and anxiety

Depressive symptoms and
affective distress.

Depression

Anxiety

Psychological quality of life

Bipolar disorder and major
depressive disorder

Depression and anxiety

Psychiatric disorder as defined
by the DSM-IV

Depression and catastrophization

Relevant symptoms/
disorder assessed

Continued

Women with endometriosis reported increased stress perception/
depressive symptoms (P < 0.05)

Women with endometriosis and chronic pelvic pain of moderate intensity
had higher levels of perceived stress (P < 0.05) and poorer mental health
quality of life than healthy controls (P < 0.001).

For women with endometriosis, there was no significant association
found between pain and anxiety and depression.

64.4% of women endorsed depression of moderate to severe severity
and 63% met study criteria for major anxiety. There were statistically
significant positive associations between current pain and measures of
anxiety symptoms.

No difference was found in depression severity, affective distress, or
pain severity between women diagnosed with endometriosis and the
comparator group.

Women with chronic pelvic pain scored higher on depression symptoms
than women with endometriosis who in turn scored higher than the health
women (F = 7.28, df = 2297 P = 0.01).

Higher anxiety was reported by the endometriosis group than the control
group but not at a statistically significant level.

The two groups of symptomatic women endorsed reduced psychological
health compared to the control group (P < 0.05).

Women with pelvic pain related to endometriosis were significantly more
likely to have a diagnosis of bipolar disorder (χ2 = 8.01, P < 0.005) but
not major depressive disorder.

48% of women in the sample had a mood condition and 99% reported
pelvic pain. Women with other comorbid pain syndromes were more
likely to report mood conditions (OR 2.01, P < 0.001).

A significant difference was found between the rate of psychiatric
disorders in women with endometriosis compared to the control group
(χ2 = 10.99, P = 0.001).

An association was identified between catastrophization and affective
pain score (β = 0.66, P = 0.01). Depression was not associated with pain
severity.

Relevant finding

Table 1. Summary of quantitative studies investigating the association between psychiatric and psychosocial distress and endometriosis

Women’s Health

40 (endometriosis)
51 (chronic pelvic pain)

40 (endometriosis)
41 (chronic pelvic pain)

14 (endometriosis)
55 (controls)

16 (endometriosis)

Peveler et al.27

Low et al.28

Walker et al.29

Lewis et al.30*

Bipolar disorder and major
depressive disorder

Bipolar disorder and major
depressive disorder

Personality variables, depression,
and anxiety

Mood symptoms, personality
characteristics, social adjustment

Depression

Psychological well-being and
stress

Relevant symptoms/
disorder assessed

In this sample, 10 (62.5%) of the women met criteria for bipolar disorder
and 2 (12.5%) met criteria for major depressive disorder.

No significant differences in prevalence of mood disorders were found.

Women with endometriosis endorsed higher levels of state anxiety
(F = 5.60, df = 1,80, P ≤ 0.05), and trait anxiety (F = 4.32, df = 1,80,
P ≤ 0.05) compared to women with pain related to other gynaecological
conditions. The two groups did not differ on pain ratings or depression
scores.

There was no significant difference in mood symptoms between the
two groups, however women in the endometriosis group reported more
“nerve trouble” than did the comparison group (χ2 = 7.50, df = 1,
P = 0.006).

86% and 38% of all women in the study sample with and without
chronic pelvic pain, respectively, met the study criteria for depression
(P < 0.001).

Women with endometriosis had fewer referrals to a psychologist. Women
with migraine headaches had better emotional functioning (P < 0.05),
less pain (P < 0.05), and less role limitations due to emotional problems
than women with endometriosis.

Relevant finding

*Indicates no control or comparison group used.

ANT: antidepressant medication; DSM-IV: Diagnostic and Statistical Manual of Mental Disorders Forth Edition; HT: hormone therapy; NSAID: non-steroidal anti-inflammatory drug; OC = oral contraceptive.

50 (endometriosis)
50 (chronic pelvic pain)
(excluded patients who had initiated any
treatment in the two months preceding study)

32 (migraines)

41 (endometriosis)

Number of sample
(pharmacological characteristics)

Lorençatto et al.26

Barnack and
Chrisler15

Source

Table 1. Continued
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Table 2. Tabulation of psychiatric diagnosis identified through clinical
diagnostic assessment
Psychiatric disorder assessed
Frequency (%)
Psychotic disorder
Bipolar disorders

Endometriosis diagnosed
Yes (n = 78)

No (n = 110)

1 (1.3)

0 (0.0)

13 (16.7)

3 (2.7)

Bipolar I disorder

1 (1.3)

Bipolar II disorder

4 (5.1)

Bipolar disorder NOS
Depressive disorders

8 (10.3)
18 (23.1)

41 (37.3)

Major depressive disorder

14 (18.0)

40 (36.4)

Depressive disorder NOS

1 (1.3)

0 (0.0)

Dysthymic disorder

3 (3.9)

1 (0.9)

10 (12.8)

3 (2.7)

Panic disorder

1 (1.3)

0 (0.0)

Generalized anxiety disorder

1 (1.3)

1 (0.9)

Specific phobia

3 (3.9)

2 (1.8)

Social phobia

1 (1.3)

0 (0.0)

Anxiety disorder NOS

4 (5.1)

0 (0.0)

Obsessive–compulsive disorder

1 (1.3)

0 (0.0)

Undifferentiated somatoform disorder

1 (1.3)

0 (0.0)

Anxiety disorders

Eating disorder NOS
Total psychiatric diagnosis identified

0 (0)

1 (0.9)

44 (56.4)

48 (43.6)

Note: NOS = not otherwise specified

for all potential psychiatric diagnoses. A tabulation of the
results from the studies by Cavaggioni et al., Kumar et al.,
and Walker et al. are presented in Table 2.16,18,29
All three studies assessed participants for major depressive
disorder and bipolar disorder. As can be seen in Table 2,
16.7% of the women with endometriosis met the criteria
for one of the forms of bipolar disorder, compared to
only 2.7% of women in the comparison group.16,18,29 In
addition, 23.1% of women in the endometriosis group had
a diagnosis of one of the depressive disorders, compared
to 37.3% of women in the comparison group. Taken
together, 35.9% of women with endometriosis and 40%
of women without endometriosis met the criteria for a
mood disorder. Only the study by Cavaggioni et al. assessed
participants for other potential disorders in either group.16
Thus, the tabulation presented here may under report
psychiatric diagnoses in these women. When considering all
potential diagnoses, 56.4% of women with endometriosis
and 43.6% of women without endometriosis met the
criteria for a psychiatric disorder. Unfortunately, due to
variation in both index and comparison groups we were
unable to draw inferences about the potential association
of pelvic pain (related and unrelated to endometriosis) and
psychiatric diagnosis.
1010 l NOVEMBER JOGC NOVEMBRE 2015

DISCUSSION

Endometriosis has been reported to be associated with
a high rate of psychiatric symptoms, namely depression,
anxiety, increased stress, and overall poor quality of life.17,31
Psychiatric comorbidity may influence the evaluation of
the disorder, because anxiety, depression, and coping
methods used may complicate the evaluation of chronic
pain and the diagnosis of endometriosis.1,16,22,23,32 In
addition, psychosocial factors may also influence the
success of interventions.1
Depression and anxiety are common comorbid conditions
that are reported in some research to be associated with
endometriosis.17 In women with endometriosis, depression
and anxiety have been found to co-occur and positively
correlate (r = 0.41, P < 0.001) with each other,33 although
it is not unusual for anxiety and depression to co-occur
together in cohorts of women without endometriosis.34
Sepulcri and Amaral found that in a sample of 104 women
with a diagnosis of pelvic endometriosis, 64.4% endorsed
moderate-to-severe depressive symptom levels and 63.5%
reported high levels of anxiety symptoms. In this sample,
age was positively correlated with depressive symptoms,
but an association was not found between age and anxiety

A Systematic Review of the Association Between Psychiatric Disturbances and Endometriosis

symptoms.22 Low and colleagues found that women with
endometriosis had higher anxiety scores and endorsed
higher levels of psychoticism and introversion than a
comparison group of women with other gynaecological
conditions.28
The prevalence of depression is reported to be greater
in women who have endometriosis with chronic pelvic
pain than in women who have endometriosis but no pain
symptoms. In the study by Lorençatto and colleagues,26
86% and 38% of the women in the study sample with
and without chronic pelvic pain, respectively, met the
study criteria for depression (P < 0.001). Depression,
somatic awareness, and catastrophization of pain were
found to be associated with pain intensity in women
who were experiencing pelvic pain.26 Thus, it may not be
endometriosis per se that is responsible for depression but
rather the experience of chronic pelvic pain. For instance,
Roth and colleagues found no difference in depressive
symptom severity or level of affective distress when
comparing women with pelvic pain due to endometriosis
to women with pelvic pain due to another somatic
condition.21 Further, Cavaggioni and colleagues recently
found that women with endometriosis had higher rates of
mood and anxiety disorders and that the prevalence was
greater in women who also experienced endometriosisrelated pain, compared to pain free women.16 Barnack
and Chrisler15 found that compared to another form of
chronic pain experience (migraine headache), women
with chronic pelvic pain endorsed greater pain and
perceived stress than did women with migraine headaches,
suggesting that factors related to the pain of endometriosis
specifically have implications for women’s mental health. It
is possible that there are differences in the pathogenesis or
consequences of the pain.
A relationship between bipolar disorder and endometriosis
has been reported in two studies.18,30 However, Walker and
colleagues failed to find evidence of this association; the
prevalence of mood disorders was not different in women
with endometriosis and women without endometriosis.29
It is important to note that half of the participants in the
study of Walker et al. were asymptomatic with respect to
the experience of pelvic pain, because research suggests
psychiatric disturbances may be a consequence of the
pelvic pain or other symptoms in endometriosis. Kumar
and colleagues found that women with endometriosis
accompanied by pelvic pain were significantly more likely
to have bipolar disorder than women who had pelvic pain
not related to endometriosis.18 These findings suggest that
there may be an association between endometriosis and
bipolar disorder beyond the experience of pelvic pain,

perhaps as a consequence of a shared pathogenesis of the
disorders such as disturbances in immune functioning.13,35
However, as noted by Kumar et al., both bipolar disorder
and endometriosis are common in women of reproductive
age, making it difficult to determine if there is a cause and
effect association.18
Combined, the results from the existing literature suggest
that psychiatric disruptions associated with endometriosis
are likely a result of women struggling with chronic pain
and its related disability or other consequences associated
with endometriosis, such as infertility, sexual dysfunction,
and the corresponding psychological consequences.21,36 It is
also possible that for some women the association is a result
of other conditions associated both with endometriosis
and mood disorders, such as autoimmune disease.37,38
Unfortunately, our current knowledge of the association
between endometriosis and psychiatric disorders is limited
because of methodological differences in the existing
research and the limited number of controlled studies.
Moreover, only two of the studies reviewed used clinical
diagnostic criteria to measure the prevalence of comorbid
psychiatric disorders.16,18 Due to the nature of the disease,
studies investigating endometriosis are often limited to
convenience samples, which may limit the generalizability
of findings.16 Further, the characteristics of the index
group varied between studies; some included women with
a diagnosis of endometriosis1,16–19,20,22–26,29 and some used
a sample of women with chronic pelvic pain secondary to
endometriosis.12,21,24,27,28 Although a number of the studies
did use a comparison group, there were salient differences
in the comparison groups used, including women with
pelvic pain not related to endometriosis,12,18,20,21,26–28 women
with other forms of chronic pain,25 women who were
infertile,19,25 and healthy women.12,16,17,20,23,24,29 Additionally,
if women are asymptomatic it does not necessarily
rule out endometriosis, and thus healthy comparison
groups may include individuals with asymptomatic
endometriosis. As the diagnosis of endometriosis requires
visualization of lesions at the time of laparoscopy or
laparotomy,4 conclusively ruling out endometriosis in
healthy individuals would require an invasive procedure.
In addition, an investigation for endometriosis often
follows symptomatic complaints, primarily infertility or
persistent pelvic pain. Both of these complaints have
been associated with psychiatric comorbidity irrespective
of cause.39,40
Symptoms of endometriosis may often be dismissed as
somatization or normal menstrual pain.41 As a result, the
diagnosis of endometriosis may not be considered by
clinicians, and this can lead to women not having a diagnosis
NOVEMBER JOGC NOVEMBRE 2015 l 1011
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or appropriate treatment for the condition until years after
the onset of symptoms.42 Vercellini et al. reported that the
severity of symptoms experienced by patients and actual
objective findings are only weakly correlated, thereby
further complicating identification of the disease.43
As the severity of pain in women with endometriosis is
not closely associated with the stage of the condition, it
has been suggested that the pain related to the disorder
has a multifactorial etiology.22,44 Vercellini and colleagues
have noted that treatment, be it medical or surgical, is
not always effective in preventing or eliminating chronic
pelvic pain.45 This may be a result of the pain related to
endometriosis stemming from nociceptive, inflammatory,
and neuropathic mechanisms.13 Some researchers have
suggested that the pain associated with endometriosis
may not dissipate with treatment or correlate with stage
of the illness because the inflammatory process causes
sensitization of nociceptors and central neurons. Thus,
it has been recommended by several authorities that if
hormonal medical management alone fails in women with
endometriosis, then medication used for management of
inflammation and neuropathic pain, such as amitriptyline
or gabapentin, should be considered.4,13,33,46
Chronic pelvic pain has been found to be associated with
negative psychological, physical, and social consequences,
including mood swings and moderate-to-severe levels
of depression and anxiety. These associated issues may
be a consequence of the long delay between the onset
of symptoms and the diagnosis of endometriosis, which
was reported by Arruda et al. to range between 3.5 and
12 years, with longer delays occurring for women who are
younger at symptom onset.47 In addition to unpleasant and
hard-to-manage symptoms, long delays before diagnosis
may result in women being subjected to prolonged pain,
increased stress, sexual dissatisfaction, and decreased selfesteem,12–14,31 which may increase the risk for psychiatric
complications.
Because endometriosis is estrogen-dependent, treatment
has traditionally sought to reduce estrogen activity.
Unfortunately, suppression of estrogen production by
the ovaries has variable effects and, for many women,
management of pain associated with endometriosis
is insufficient.13 Specific medical and pharmaceutical
management of endometriosis may include treatment
with continuous or cyclic combined oral contraceptives,
progestogens, gonadotropin-releasing hormone (GnRH)
agonists with or without add-back hormonal therapy,
progestin-releasing intrauterine systems, danazol, and
laparoscopic surgical excision of the endometriotic
lesions.4,13,17
1012 l NOVEMBER JOGC NOVEMBRE 2015

Some of the treatment options for endometriosis are
associated with adverse side effects including the experience
of psychiatric symptoms. For instance, oral contraceptives
have been associated with adverse psychiatric side effects
in some women. Reported side effects include decreased
psychosexual arousal or negative changes in mood.48 A
history of depression, psychiatric distress, premenstrual
mood symptoms prior to oral contraceptive use,
dysmenorrhea, or antenatal and postnatal mood symptoms
have also been reported to increase the risk for psychiatric
disturbance related to oral contraceptive use.49
GnRH agonists suppress ovarian hormone production
and may be used to treat endometriotic lesions and
associated pelvic pain.50 However, GnRH agonists used to
treat endometriosis have been found to be associated with
emotional lability and depression.51 Physical and psychiatric
side effects associated with GnRH agonist therapy have
been thought to be related to the reduction in plasma
concentrations of estrogen and testosterone. Prophylactic
treatment with an antidepressant when initiating GnRH
antagonist treatment may reduce the risk for the experience
of treatment-induced mood symptoms.50
Tripoli and colleagues found that untreated depression
influenced a patients’ ability to cope with pain and
could impede daily functioning and quality of life.12
Consequently, some authorities have recommended
antidepressants as adjunctive treatment for chronic pelvic
pain,52 regardless of the treatment for endometriosis being
used. However, because women with endometriosis may
also present with an elevated risk for bipolar disorder,
the use of antidepressants should be considered only
after bipolar disorder has been ruled out.53,54 In addition,
as antidepressants have been found to induce mania in
susceptible individuals, women with endometriosis should
be carefully monitored for manic symptoms when initiating
treatment with an antidepressant.18,53,54
This review is limited by the paucity of research to date and
the variability in sample characteristics. We did not include
studies published in languages other than English in our
review. Our review also was limited by methodological
differences between original studies because the
characteristics of the index group (such as the inclusion
or exclusion of women without pelvic pain related to the
diagnosis of endometriosis) varied between studies. The
characteristics of the control groups used (i.e., pelvic pain
not related to endometriosis, women with other forms of
chronic pain, women who were infertile, healthy women)
also varied between studies. Most studies did not provide
specific information about pharmacological, surgical,
or psychosocial interventions being used by patients
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in their sample. As researchers have recently found that
interventions have the potential to attenuate or encourage
psychiatric symptoms, such information would be valuable
when interpreting the literature and should be considered
in future investigations.
There is clearly a pressing need for more research to
better understand the relationship between endometriosis
and psychiatric disorders. The investigations to date
vary in methodology, and only three studies to date have
used diagnostic criteria to confirm diagnosis. Only one
study in this review investigated the co-occurrence of
psychiatric disorders beyond mood disorders in relation
to endometriosis. Larger and better-controlled studies are
required to ascertain if there is in fact a higher prevalence
of psychiatric disorders in women with endometriosis.
These studies should examine the range of potential
psychiatric diagnoses and potential comorbidity using
structured clinical diagnostic interviews. The experience
and severity of pain related to endometriosis should
also be assessed to determine the potential relationship
between endometriotic pain symptoms and psychiatric
disorders. Because pelvic pain is not the only source of
pain or discomfort experienced as a consequence of
endometriosis, future research should examine various
gynaecological pain symptoms in relation to psychiatric
disorders.
Despite the sparse and conflicting research findings, there
appears to be sufficient evidence to suggest a relationship
between endometriosis (or chronic pelvic pain) and an
increased risk of psychosocial symptoms compared to
women who do not report chronic pelvic pain. Thus, until
more definitive evidence is available, we suggest that women
with endometriosis or chronic pelvic pain be screened for
psychiatric comorbidity, especially when there is severe
pelvic pain present. Potential screening instruments may
include the Mood Disorder Questionnaire55 to assess for
manic symptoms and the Beck Anxiety Inventory56 and
the Beck Depression Inventory II57 to assess for anxiety or
depression. If warranted, a more comprehensive clinical
assessment to confirm diagnosis may include the Structured
Clinical Interview for DSM-IV Axis I disorders58 or the
MINI International Neuropsychiatric Interview.59
The research evidence also suggests that after beginning
treatment for endometriosis, women should be monitored
for psychiatric side effects. Women who do experience
psychiatric complications may require pharmacological
or psychosocial interventions. Initial research suggests
that antidepressant therapy may reduce both depressive
symptoms associated with endometriosis and depressive
symptoms associated with some treatments for

endometriosis.50,52 Preliminary evidence by SatorKatzenschlager et al. suggests that some medications
used to treat psychiatric disorders (including gabapentin
and amitriptyline) may also be effective in treating
chronic pain symptoms and thus may be beneficial for
some women with endometriosis.46 Psychosocial therapy
may be of benefit in treating physical and psychiatric
symptoms associated with chronic pelvic pain related
to endometriosis.14,31 For example, Kold and colleagues
have suggested that mindfulness-based therapy may help
women with endometriosis reduce perceived pain and
improve well-being and daily functioning.14 However, as
research on psychosocial interventions for women with
endometriosis is limited, future studies could extend these
initial findings.
CONCLUSION

Understanding the relationship between psychiatric
disturbance and pain expression in women with chronic
pelvic pain due to endometriosis can be very challenging
for clinicians. The experience of chronic pelvic pain
may promote psychiatric conditions such as depression
or anxiety, thus mediating the relationship between
endometriosis and psychiatric disturbances. Alternatively,
psychiatric disturbance may exacerbate perceived pain levels
and may complicate patients’ responses to treatment and
their overall prognosis. In addition to chronic pain, women
with endometriosis also often encounter other difficulties
that may influence their well-being, including infertility,
social isolation, and relationship difficulties, which could
also mediate the relationship between endometriosis
and psychiatric disorders. Alternatively, if a relationship
between psychiatric disorders and endometriosis is
established in future research, it may be shown that an
alternative physiological factor, such as inflammation,
is responsible for both disorders. Future studies should
control for the influence of endometriosis treatment, as
such treatment may also be associated with psychiatric
disturbances. We recommend that women presenting
with chronic gynaecological pain or endometriosis also be
assessed for potential social, relationship, and psychiatric
disturbances.
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